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ABSTRACT Filamentous fungi of the genus Aspergillus are of particular interest for
biotechnological applications due to their natural capacity to secrete carbohydrate-
active enzymes (CAZy) that target plant biomass. The presence of easily metaboliz-
able sugars such as glucose, whose concentrations increase during plant biomass
hydrolysis, results in the repression of CAZy-encoding genes in a process known as
carbon catabolite repression (CCR), which is undesired for the purpose of large-
scale enzyme production. To date, the C2H2 transcription factor CreA has been
described as the major CC repressor in Aspergillus spp., although little is known
about the role of posttranslational modifications in this process. In this work, phos-
phorylation sites were identified by mass spectrometry on Aspergillus nidulans CreA,
and subsequently, the previously identified but uncharacterized site S262, the character-
ized site S319, and the newly identified sites S268 and T308 were chosen to be mutated
to nonphosphorylatable residues before their effect on CCR was investigated. Sites S262,
S268, and T308 are important for CreA protein accumulation and cellular localization,
DNA binding, and repression of enzyme activities. In agreement with a previous study,
site S319 was not important for several here-tested phenotypes but is key for CreA deg-
radation and induction of enzyme activities. All sites were shown to be important for
glycogen and trehalose metabolism. This study highlights the importance of CreA phos-
phorylation sites for the regulation of CCR. These sites are interesting targets for bio-
technological strain engineering without the need to delete essential genes, which
could result in undesired side effects.
IMPORTANCE In filamentous fungi, the transcription factor CreA controls carbohy-
drate metabolism through the regulation of genes encoding enzymes required for
the use of alternative carbon sources. In this work, phosphorylation sites were identi-
fied on Aspergillus nidulans CreA, and subsequently, the two newly identified sites
S268 and T308, the previously identified but uncharacterized site S262, and the pre-
viously characterized site S319 were chosen to be mutated to nonphosphorylatable
residues before their effect on CCR was characterized. Sites S262, S268, and T308 are
important for CreA protein accumulation and cellular localization, DNA binding, and
repression of enzyme activities. In agreement with a previous study, site S319 is not
important for several here-tested phenotypes but is key for CreA degradation and
induction of enzyme activities. This work characterized novel CreA phosphorylation
sites under carbon catabolite-repressing conditions and showed that they are crucial
for CreA protein turnover, control of carbohydrate utilization, and biotechnologically
relevant enzyme production.
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In recent years, the conversion of plant biomass waste to biofuels, in a process called1st- (1G) and 2nd-generation (2G) biofuel production, has gained significant interest
as an environmentally friendly and naturally abundant alternative renewable energy
source. Saprobic microorganisms, such as filamentous fungi of the genus Aspergillus,
are of particular interest in this process as they secrete a vast array of plant biomass-
hydrolyzing enzymes. Plant biomass is composed of complex carbohydrates (cellulose
and hemicelluloses), and enzymatic hydrolysis of these complex carbohydrates by the
simultaneous action of several plant biomass-degrading enzymes results in the release
of monosaccharides (e.g., glucose and xylose) that are used in fermentation processes
to generate renewable biofuels. The genes that encode these enzymes are under tight
transcriptional control (1, 2) and are repressed in the presence of easy metabolizable
sugars such as glucose, whose concentrations increase during plant biomass hydrolysis.
Glucose-mediated repression of these enzyme-encoding genes is known as carbon
catabolite repression (CCR) (1, 3, 4) and is undesired for the purpose of large-scale
enzyme production (2, 5). To date, the C2H2 transcription factor (TF) CreA has been
described as the major regulator of CCR in Aspergillus spp. (1, 3, 6), although it has
become evident that its role goes beyond that of solely a CC repressor, with suggested
roles in amino acid metabolism, establishment and progression of infection, enzyme
production, carbohydrate storage, production of secondary metabolites (SM), and
chromatin remodeling (7–13). In Aspergillus nidulans, truncation of creA resulted in
strain creAd30, which had significantly reduced intracellular concentrations of the carbo-
hydrate storage compound trehalose (9). This effect on cellular trehalose concentrations
was also observed for the Aspergillus fumigatus DcreA strain (14). In addition, glycogen me-
tabolism in fungi is regulated by CreA homologues, with the deletion of nonessential creA
causing a hyperaccumulation of glycogen in these fungi (14–16). In A. fumigatus, a prelimi-
nary in silico analysis found a putative CreA binding site in the 59 untranslated region
(UTR) of the glycogen debranching enzyme-encoding gene gdbA, whose expression was
significantly reduced in the DcreA strain (14). Furthermore, in A. fumigatus, increased accu-
mulation of intracellular glycogen is controlled by the protein kinase A (PKA) pathway (14),
suggesting that PKA is involved in the direct or indirect regulation of CreA.
In A. nidulans, the CreA protein is composed of 416 amino acids, with two N-termi-
nal zinc finger domain regions at amino acids 64 to 86 and 92 to 116 and an N-terminal
alanine-rich region composed of amino acids 131 to 139 (Fig. 1a). The C-terminal region of
CreA contains the acidic region, located at amino acids 264 to 271, a highly conserved
region (called conserved because it is almost identical between A. nidulans, Aspergillus ni-
ger, and Trichoderma reesei) at amino acids 271 to 315, and a repressive region composed
of amino acids 336 to 361, which has been shown to be essential for repression (Fig. 1a)
(2, 13, 17). CreA represses xylanase-encoding genes such as xlnA, xlnB, and xlnD by directly
binding to the 59-SYGGRG-39 promoter consensus region (18). Furthermore, CreA also reg-
ulates alcR, the TF that adjusts ethanol metabolism via alcohol dehydrogenase activity
(19). Repression of target genes by homologues of CreA has been studied in detail in vari-
ous fungi (8, 20–22), whereas few studies exist that investigate regulation of CreA itself.
Mechanisms of CreA regulation comprise (i) inclusion and exclusion of the nucleus in a car-
bon source-dependent manner, (ii) protein-protein interactions, and (iii) posttranslational
modifications. Correct cellular localization of CreA (1, 3, 23) was not sufficient for repression
alone, suggesting that CreA undergoes posttranslational modifications and/or interacts
with corepressors such as RcoA and SsnF, which have been shown to be required for full
functionality (24–26). A. nidulans CreA is degraded in the presence of the alternative car-
bon source xylan (CC-derepressing condition), a process that is mediated by the ubiquity-
lation-dependent Fbx23 F-box complex (24). To date, it remains unclear whether CreA or
an interaction partner of this TF is subject to ubiquitylation (13, 24). In addition to A. nidu-
lans CreA interacting with the corepressors RcoA and SsnF, it also physically interacts with
glycogen synthase kinase A (GskA) and casein kinase A (CkiA) under CC-derepressing
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FIG 1 Diagram of CreA protein domains and phosphorylation sites. (a) Schematic diagrams of CreA protein domains. The top shows CreA protein
domains and their localization: zinc fingers (blue), alanine rich (yellow), acidic (dark orange), conserved (light orange), and repressive (green). The
middle shows CreA phosphorylation sites, as predicted by NetPhos3.1 on the entire length of the protein. The bottom shows CreA phosphorylation
sites, as identified by nLC-MS/MS, when the wild-type strain was exposed to 2% (wt/vol) glucose for 30min. In red are the sites that were
experimentally confirmed in this work. (b) Alignment of A. nidulans CreA and homologues of different fungi (yeast and filamentous). The
phylogenetic tree shows the closeness between proteins from each fungus; conserved regions are shown in red inside the boxes, and a red box
means conserved in all organisms. Highlighted in blue are the phosphorylation sites characterized in this work; highlighted in black are additional
phosphosites that were experimentally identified. (c) Strains were grown from 105 spores on glucose minimal medium (MM) for 5 days. Graphs
representing radial growth (colony diameter) of strains in glucose (d) or xylose minimal medium (MM) supplemented with increased concentrations
of 2DG (2-deoxyglucose) and AA (allyl alcohol) (e). Growth is given as the percentage normalized to the control (without 2DG, AA) condition for each
strain. Standard deviations represent the averages from three biological replicates (depicted in orange). *, P , 0.05; **, P , 0.001 in a two-way
ANOVA multiple-comparison test using the WT (wild-type) strain as a reference for each condition.
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conditions (24). Deletion of gskA results in a strain that is severely compromised in growth;
however, studies using GskA-green fluorescent protein (GFP) showed that in the presence
of glucose, GskA is predominantly cytoplasmic and loses interaction with the CreA com-
plex (24). On the other hand, CkiA is localized throughout the cytoplasm and nucleus (27),
and studies using thiamine promoter-induced repression of ckiA showed that CkiA is
involved in CCR (24).
Interactions with protein kinases is further evidence that CreA is subject to post-
translational modifications such as phosphorylation. CreA was shown to be phospho-
rylated at S319, with an S319A mutation causing hyperaccumulation of CreA within
the cell (28). Additional phosphorylation sites on CreA have also been identified under
CCR conditions, including S262, S288, S289, and S319, whereas sites S262 and S288
were identified under CC-derepressing conditions; although, these sites remain
uncharacterized (29). In T. reesei, mutation of the CRE1 (CreA homologue) serine 241 to
alanine (S262 in A. nidulans) resulted in impaired DNA binding and an alleviation in
CCR (30). Genes encoding CreA and its homologues are essential depending on the
fungal species.
In this work, we identified phosphorylation sites by liquid chromatography-tandem
mass spectrometry on A. nidulans CreA under CCR conditions. Subsequently, we further
characterized four sites predicted to be phosphorylated by the protein kinases CkiA (S262
and S268), GskA (T308), and Stk22 (indirectly regulated by PkaA-S319) by mutating them
to an alanine, thus creating sites that cannot be phosphorylated (hypophosphorylation).
We show that these sites are crucial for CCR and CreA cellular localization in the presence
of glucose and the hemicellulose xylan as well as for DNA binding, xylanase gene expres-
sion, and enzyme activity. Furthermore, these CreA phosphorylation sites are important for
glycogen and trehalose metabolism. Finally, this study shows that these point mutations
affect CreA protein stability and/or accumulation under different conditions. In summary,
this is a comprehensive study that further characterizes the importance of posttranslational
modifications on the regulator of CCR CreA in the reference fungus A. nidulans and pro-
vides further insights into the complex dynamics that underlie the utilization of carbon
sources in filamentous fungi.
RESULTS
Identification of phosphorylation sites on CreA. Previous work has shown that
CreA physically interacts with the protein kinases glycogen synthase kinase A (GskA) and
casein kinase A (CkiA) under carbon catabolite (CC)-derepressing conditions, suggesting
targeted phosphorylation of this TF (24). We therefore decide to first scan for predicted
GskA- and CkiA-mediated phosphorylation sites on CreA using NetPhos 3.1 (31, 32).
Phosphorylation sites catalyzed by these two protein kinases were predicted to occur at
S172, S176, S216, S262, S268, S281, S288, S289, T300, T308, S312, S336, and S368, with the
majority of these sites occurring within the CreA acidic and conserved domains (Fig. 1a).
To identify CreA posttranslational modifications in vivo, liquid chromatography-tandem
mass spectrometry (LC-MS/MS) was carried out for the detection of phosphorylation, ubiq-
uitylation, and sumoylation sites when the CreA-GFP strain was grown in minimal medium
(MM) supplemented with xylan (CC-derepressing condition) for 24 h and after the addition
of 2% glucose (induction of CCR) for 30min (data available in the PRIDE [Proteomics
Identification Database] under accession number PXD018967). Subsequently, immunopre-
cipitation (IP) of the CreA-GFP fusion protein was carried out. We included ubiquitylation
and sumoylation in order to determine whether CreA is subject to posttranslational modifi-
cations other than phosphorylation, especially as ubiquitylation has been shown to play a
role in CreA protein dynamics (13). We were unable to identify statistically significant CreA
posttranslational modifications in the presence of xylan, likely due to CreA being degraded
in the cytoplasm under CC-derepressing conditions (13, 24). In the presence of glucose
(CCR), ubiquitylation and sumoylation were not identified on CreA. Both posttranslational
modifications are related to degradation processes, with ubiquitylation being used to tag
proteins for 26S proteasome degradation and sumoylation being targeted by SUMO
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ubiquitin ligases that can use SUMO moieties to introduce ubiquitylation (33). In agree-
ment with previous studies (13, 24), these results suggest that CreA is not directly targeted
for degradation by ubiquitylation and sumoylation processes in the presence of glucose.
In contrast, several phosphorylation sites were identified under CCR conditions (see Table
S1 available at 10.6084/m9.figshare.13181990). Again, the majority of these sites were
identified near to and/or within the acidic and conserved domains (Fig. 1a), both of which
are required for CreA-GFP translocation into the cytoplasm under CC-derepressing condi-
tions (13).
To determine whether these phosphorylation sites are also present in other fungal spe-
cies, an alignment of CreA and its homologues in Saccharomyces cerevisiae, Cryptococcus
neoformans, Candida albicans, A. nidulans, A. fumigatus, Neurospora crassa, Trichoderma ree-
sei, and Fusarium graminearum was carried out. Indeed, CreA homologues from filamen-
tous fungi show phosphorylatable residues for all the sites identified by MS in the A. nidu-
lans acidic and conserved domains except for S268, which was exclusively found in A.
nidulans. Furthermore, identified residues, with the exception of S281, are either absent or
have been replaced by nonphosphorylatable residues in the yeast species (Fig. 1b). The
aim of this work was to characterize the effect of one specific phosphosite on CCR; hence,
CreA double and triple point mutations were not investigated. Subsequently, phosphosites
identified in this work and in previous studies were chosen for further characterization, as
they are good representatives of phosphosites located in the acidic and conserved target
phosphorylation hot spot regions of CreA. We chose S262 and S268 to be mutated to ala-
nines, as these two residues were identified both in silico and in vivo, are located close to
and within the acidic domain, and are present in filamentous fungi but not in yeast
(Fig. 1b). Furthermore, S268 is unique to A. nidulans, which makes it a highly interesting
target to investigate (Fig. 1b). Next, we chose a site located within the conserved region to
be mutated. A total of 5 (S277, S281, S284, T308, and S312) sites were identified in the con-
served region in vivo. We chose to mutate T308 to alanine, as this residue was identified in
silico and in vivo (as opposed to S277 and S284), is located within the conserved region,
and is present in both filamentous and yeast-like fungi. Although S312 is highly conserved
between the here-analyzed species, this phosphosite was not characterized in this work
because it, together with an additional site (S281) identified in different carbon sources, is
the subject of another work in progress. Finally, we also included S319 in this analysis as a
control, as this residue was previously identified as a phosphorylation target (28). CkiA is
predicted to phosphorylate S262 and S268, and GskA is predicted to target T308 for phos-
phorylation. The site S319 has been experimentally confirmed to be the target of the pro-
tein kinase Stk22 (Sak1p homologue in S. cerevisiae, responsible for Snf1 activation [34]),
which in turn is indirectly regulated by protein kinase A (PkaA). Mutation of these sites to
an alanine mimics constant hypophosphorylation and allows us to determine the role of
these phosphorylation sites for CreA function and CCR.
CreA phosphomutations result in strains with defects in CCR. Point mutations
(S262A, S268A, T308A, and S319A) were generated in the CreA-GFP background, result-
ing in four strains. Strains S262A and S268A had the same growth phenotype as the
wild-type (WT) strain, whereas strains T308A and S319A showed a dark green circle in
the colony center compared to the WT strain in the presence of glucose (Fig. 1c). It is
possible that these two sites are involved in developmental and conidiation processes,
although growth fitness was not affected, with the exception of strain T308A, which
grew significantly more (7%) than the WT strain at 37°C in minimal medium supple-
mented with glucose (see File S1 available at 10.6084/m9.figshare.13181990). Radial
growth on plates of all strains was first assessed in the presence of the compounds allyl
alcohol (AA) and 2-deoxyglucose (2DG), which are indicators for defects in CCR. AA is
an alcohol that is metabolized to the toxic compound acrolein, and defects in CC dere-
pression usually manifest themselves in strains with increased sensitivity to this com-
pound (17, 25, 35). 2DG is a glucose analogue which, when metabolized, forms 2-
deoxy-glucose-6-phosphate with the absence of the hydroxyl group on C-2 preventing
further metabolism, resulting in its accumulation and inhibition of glycolysis (36).
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Strains with defects in CCR are more resistant to this compound and show reduced
glucose uptake due to ability to metabolize different sugars in addition to glucose.
Strains containing the point mutations S262A, S268A, and T308A were significantly
more sensitive to 40mM AA, while growth of the S319A strain was similar to that of
the wild-type (WT) strain (Fig. 1d). Strains with the point mutations S262A and T308A
were resistant to at least at one concentration of 2DG compared the resistance of the
WT strain, whereas the S268A strain had similar growth to that of the WT strain
(Fig. 1e). The strain containing the S319A mutation was significantly more sensitive to
lower concentrations of 2DG but not to higher 2DG concentrations (Fig. 1e). These
results suggest that the S262A and T308A mutations are important for CCR, whereas
the strain with the S268A mutation showed a CCR-derepressing phenotype for AA
only.
CreA phosphomutations affect DNA binding. In filamentous fungi, CreA regulates
the expression of genes encoding enzymes required for alternative carbon source utili-
zation, such as alcohol dehydrogenases (ADHs) and xylanases, through direct binding
to the respective promoter regions (17, 18). We performed chromatin immunoprecipi-
tation coupled to DNA sequencing (ChIP-seq) in order to determine whether the CreA
phosphomutations impact CreA-GFP DNA binding dynamics in the simultaneous pres-
ence of xylan and glucose (induction of CCR and target promoter binding). Several ex-
perimental phosphosites were identified, among which, 4 representative phospho-
sites were chosen for point mutation, replacing the phosphosite with alanine for
further ChIP-seq experiments (Fig. 2a). ChIP-seq results (NCBI accession number
SUB7547091) show that CreA-GFP binds to several promoter regions of genes
encoding enzymes required for ethanol, trehalose, and xylan/xylose utilization
(Fig. 2b). In the presence of xylan and glucose, CreA-GFP bound to the promoter
regions of the ADH alcA and the transcriptional regulator of alcohol metabolism
alcR. The DNA binding to alcA was reduced in the S262A and T308A strains and
increased in the S319A strain (Fig. 2b). Moreover, DNA binding in the S262A, S268A,
and T308A strains was severely reduced at the promoter region of the TF alcR, the main
regulator of alcohol metabolism and a known CreA target (37). Furthermore, DNA bind-
ing was also reduced in the S262A, S268A, and T308A strains for the trehalase-encoding
gene treA, required for trehalose metabolism (Fig. 2b). Interestingly, creA is subject to
self-binding and autoregulation, with strains harboring the phosphomutations S262A,
S268A, and T308A showing significantly reduced binding (Fig. 2b).
In the presence of xylan and glucose, binding to the promoter regions of the TF
XlnR, the xylanase-encoding gene xlnD, the xylose transporters XtrA to -D, the xylulose
reductase XdhA, the alpha fucosidase AfcA, and the esterases FaeC and AN3294 was
observed (Fig. 2c). Four (xlnA, xlnB, xlnC, and xlnD) of five of the A. nidulans xylanase-
encoding genes have been shown to be under the transcriptional control of XlnR and
of CreA-mediated CCR in a carbon source-dependent manner (18, 20, 38), whereas reg-
ulation of the fifth xylanase-encoding gene xlnE remains unknown. CreA-GFP with the
S268A, T308A, and S319A phosphomutations had significantly reduced binding to the
xlnR promoter region compared to that in the WT strain in the presence of xylan and
glucose (Fig. 2c and d). In addition, CreA-GFP binding in the S268A, T308A, and S319A
strains was also reduced for several promoter regions of genes involved in xylan/xylose
metabolism (Fig. 2e). Conversely, binding of CreA-GFP in the S262A strain was increased
compared to that in the WT strain for most of the xylan/xylose genes (Fig. 2c and e). In
summary, CreA-GFP DNA-binding affinities to promoter regions of genes encoding
enzymes required for ethanol, trehalose, and xylan/xylose utilization were altered
in the phosphomutants. The strain S262A had similar binding as the WT strain for
xylan/xylose genes and reduced binding to alcohol and trehalose metabolic genes.
The mutants S268A and T308A consistently showed reduced binding to all here-
investigated target DNA regions, whereas binding to xylan/xylose metabolic genes
in the S319A strain was similar to that in the control strain. These results therefore
suggest that targeted protein phosphomutation affects CreA TF DNA-binding affinities.
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FIG 2 Summary of CreA phosphomutant phenotypes. (a) Diagram showing CreA protein localization and experimental phosphorylation sites identified by
nLC-MS/MS, when the wild-type strain was incubated in minimal medium supplemented with 2% (wt/vol) glucose for 30min. Experimentally identified
CreA phosphosites are shown in black, and the four here-characterized phosphosites are shown in red. Heat map of CreA-GFP binding affinities, as
determined by ChIP-seq under the same condition as described for panel a in the WT, S262A, S268A, T308A, and S319A strains showing creA and genes
involved in alcohol and trehalose metabolism (b) and xylan/xylose metabolism (DNA-binding affinity average of three replicates is shown as a number in
the center of each square) (c). (d) Integrative genome viewer of the xlnR promoter region showing reduced DNA-binding affinity in the S268A, T308A, and
S319A strains. (e) Average CreA-GFP DNA-binding affinity, as identified by ChIP-seq, for all xylan/xylose genes in each CreA phosphomutation-harboring
strain. Statistical analyses via two-way ANOVA multiple-comparison test using the WT as a reference.
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To support our ChIP-seq data, reverse transcription-quantitative PCR (qRT-PCR)
studies on xlnA gene expression were performed in the presence of xylan or xylan and
glucose. Results showed significant gene expression in the presence of glucose and
xylan after 30min in strains S262A, S268A, and T308A compared to that in the WT
strain (Fig. 3). Similarly, xlnA expression was significantly increased in the presence of
xylan in strains S268A, T308A, and S319A after 30min and in strains S268A and T308A
after 60min compared to that in the WT strain (Fig. 3). In addition, strain S262A showed
increased expression of xlnA in the presence of glucose and xylan after 60min of treat-
ment (Fig. 3). These results suggest that the CreA phosphomutations impact transcrip-
tional expression of xlnA. Furthermore, xlnA expression in the presence of xylan and glu-
cose does not always reflect the ChIP-seq data, with binding to the xlnR promoter not
being affected in the S262A strain. In the S319 strain, xlnA expression was not different
from that in the WT strain, although CreA-GFP binding was significantly reduced in this
strain. In contrast, xlnA expression was significantly induced in the S268A and T308A strain
after a 30-min incubation in xylan and glucose, which agrees with the ChIP-seq data,
where significantly reduced binding to the xlnR promoter region was observed. These
results suggest that additional mechanisms, other than DNA binding, exist and impact
CreA-mediated CCR, including competition between transcription factors for promoter tar-
get site binding. The pH-responsive TF PacC has been shown to indirectly regulate xlnA
expression, and two PacC-binding consensus sequences are present in the xlnA promoter
region, although their functionality has not been tested to date (39).
CreA phosphomutations affect CreA-GFP cellular localization. A possible addi-
tional mechanism that controls CCR is the cellular localization of CreA-GFP. The pres-
ence of glucose causes CreA to translocate to the nucleus where it causes gene repres-
sion (3). To determine whether the phosphomutations affect CreA cellular localization
under both CC-derepressing and CCR conditions, strains were grown for 16 h in mini-
mal medium (MM) supplemented with 1% ethanol or 1% xylan (CC derepression). After
the addition of 2% glucose (to induce CCR) and further incubation for 30min, micros-
copy was carried out. In agreement with other studies (3, 13, 24), around 20% of WT
CreA-GFP was nuclear in the presence of ethanol and xylan, while the addition of glu-
cose caused 100% nuclear localization in this strain (Fig. 4a and b). Strains containing
FIG 3 The expression of the xylanase-encoding gene xlnA is increased in the CreA phosphomutants.
Strains were grown for 24 h in minimal medium (MM) supplemented with fructose and then transferred
to MM supplemented with xylose or xylose and glucose for 30min and 60min. Total mRNA was
extracted and reverse-transcribed to cDNA, and RT-qPCR was performed. Gene expression was normalized
by the tubulin-encoding gene tubC. Standard deviations represent the averages from three biological
replicates. *, P , 0.05; ***, P , 0.001 in a two-way ANOVA multiple-comparison test using the WT as a
reference for each condition.
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the S262A and S268A mutations showed increased CreA-GFP nuclear localization under
derepressing conditions compared to that in the WT strain (Fig. 4a and b). In contrast, the
other two phosphomutations had no significant effect on CreA-GFP cellular localization
under these conditions, with the exception of the T308A strain, which showed significantly
reduced nuclear localization in the presence of xylan (Fig. 4a and b). Upon the addition of
glucose, nuclear localization of the strain containing the S262A mutation did not change
compared to that under the CC-derepressing condition and was significantly lower than
that observed for the WT strain, suggesting that this mutation “keeps” CreA-GFP locked in
the nucleus, affecting the ability to move out (Fig. 4a and b). The mutation S268A resulted
in increased nuclear accumulation of CreA-GFP in the presence of glucose, albeit to signifi-
cantly lower levels than in the WT strain, suggesting that this mutation is also important
for CreA-GFP cellular localization under CCR conditions (Fig. 4a and b). The nuclear localiza-
tion of CreA-GFP in the T308A strain in the presence of glucose was similar to that under
CC-derepressing conditions and significantly reduced compared to that in the WT strain,
suggesting that this mutation is required for CreA translocation and/or accumulation in
the nucleus (Fig. 4a and b). In contrast, cellular localization patterns for the S319A muta-
tion-harboring strain were similar to those for the WT strain.
CreA phosphomutations affect enzyme activities for alternative carbon source
utilization. The aforementioned results show that CreA phosphomutations affect
DNA-binding affinity, target gene expression, and cellular localization. To determine
the impact on the proteins, we assayed the activities of alcohol dehydrogenase (ADH)
FIG 4 CreA phosphomutations affect cellular localization and enzyme activities. Percentages of nuclear CreA-
GFP localization, as determined by fluorescence microscopy of strains grown for 16 h at 22°C in minimal
medium (MM) supplemented with ethanol (a) or xylan (b) and after the addition of 2% glucose for 30min.
Nuclei were counted for at least 100 hyphal germlings and stained with Hoechst 33258 to confirm GFP
fluorescence localization. Percentage represents nuclear CreA-GFP in comparison to total counted nuclei. (c)
Alcohol dehydrogenase (ADH) activity is increased in the S262A and T308A phosphomutants in the presence of
ethanol and glucose. Strains were grown in MM supplemented with fructose (noninducible) for 24 h and then
transferred to MM supplemented with ethanol and glucose or ethanol only for 2 h. ADH activity was measured
in mycelial protein extracts and normalized by total intracellular protein. (d) Xylanase activity is impaired in the
phosphomutants. Strains were initially grown as described for panel c and then transferred to MM supplemented
with xylose and glucose or xylose for 24 h, 48 h, and 72 h, before xylanase activity was measured in culture
supernatants. Standard deviations represent the averages from three biological replicates (shown as orange
symbols). *, P , 0.05; **, P , 0.01; ***, P , 0.001 in a two-way ANOVA multiple-comparison test using the WT
(wild-type) strain as a reference for each condition.
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and xylanases, whose genes are known to be transcriptionally regulated by CreA (17,
18, 40–42), in the point mutation-harboring strains. Strains were first grown in MM sup-
plemented with fructose (noninducing, nonrepressive carbon source) and mycelia
were subsequently transferred to MM supplemented with ethanol (ADH induction),
ethanol and 2% glucose, xylan, or xylan and 2% glucose. ADH activity increased in the
presence of ethanol in the WT strain and was at a basal level in the presence of glucose
(Fig. 4c). ADH activity in the strains harboring the S268A and S319A mutations was sim-
ilar to that in the WT strain (Fig. 4c). In contrast, ADH activity in the presence of ethanol
and glucose in the S262A-harboring strain was similar to that in the WT strain in the
presence of only ethanol, suggesting that this mutation inhibits CC-induced repression
of ADH (Fig. 4c). Lastly, ADH activity in the T308A-harboring strain was reduced in the
control condition and significantly increased in the presence of ethanol and glucose
but did not differ from that in the WT strain in the presence of ethanol, again suggest-
ing that glucose-mediated CCR did not result in ADH transcriptional repression in this
strain (Fig. 4c).
Next, we quantified xylanase activities of culture supernatants every 24 h over 72 h
due to xylan being a complex carbon source, which, when degraded, results in a grad-
ual release of enzyme-inducing mono- and polysaccharides (43). In agreement with
other studies (13, 24), xylanase activity was at a basal level in the presence of xylan and
glucose in the WT strain but increased with prolonged incubation times, due to the
complete consumption of available extracellular glucose (Fig. 4d). In the WT strain,
xylanase activity was much higher in the presence of xylan than in the presence of
xylan and glucose and also increased with prolonged incubation times (Fig. 4d). In the
simultaneous presence of glucose and xylan, strains harboring the S262A, S268A, and
T308A mutations, but not the S319A mutation, had significantly increased xylanase ac-
tivity after 72 h compared to that in the WT strain (Fig. 4d), suggesting defects in CCR.
In the presence of xylan, the S262A strain had significantly increased xylanase activity
after 24 h and 48 h compared to that in the WT strain (Fig. 2d). It should be noted that
enzyme activity in this strain remained the same at all tested time points, and no grad-
ual increase in activity was observed, suggesting CC derepression at all tested time
points. The strains S268A and T308A presented significantly increased xylanase activity
after 72 h in the presence of xylan and glucose compared to that in the WT strain
(Fig. 4d). In contrast, xylanase activity in culture supernatants of the S319A strain in the
presence of xylan was significantly reduced at all the assayed time points (Fig. 4d), sug-
gesting that this mutation affects CC derepression.
In summary, these CreA phosphomutations affect CreA cellular localization and
cause defects in CCR and CC derepression. The S262A mutation results in a strain that
is blind to glucose as a carbon source, as CreA nuclear localization did not change
between CCR and CC-derepressing conditions. Similarly, the S268A phosphomutation
causes increased CreA nuclear localization under CC-derepressing conditions, decreased
nuclear localization under CCR conditions, and xylanase activity that is significantly higher
under all conditions, suggesting that this mutation also impairs glucose utilization and/or
signaling. The T308A mutation mainly affects CCR, with CreA being excluded from the nu-
cleus and enzyme activities being significantly increased in the presence of glucose and at
the latest incubation time points. Lastly, the S319A mutation does not impact CreA cellular
localization and ADH activity, whereas xylanase activity was significantly reduced, suggest-
ing that this mutation does not impact transcriptional regulation (similar xlnA levels and
binding affinity to xylan-encoding genes compared to those for the WT strain) of xylanase-
encoding genes, but rather impacts a region of CreA that is important for xylanase secre-
tion and/or translation.
CreA phosphomutations affect protein accumulation. Based on the aforemen-
tioned results, we turned our attention to posttranslational mechanisms which have
been shown to also be involved in the regulation of CreA function. A previous study
has shown that CreA partially relies on de novo synthesis and that low cytoplasmic lev-
els of this protein are always present, thus allowing the fungus to rapidly respond to
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and scavenge for extracellular glucose concentrations (13). To determine whether the
phosphomutations affect CreA protein levels under both CC-derepressing and CCR
conditions, the WT, S262A, S268A, T308A, and S319A strains were grown in MM supple-
mented with xylose for 24 h before 2% glucose was added for 30min, immunoprecipi-
tation was carried out on whole-cell protein extracts, and Western blotting was per-
formed using an anti-GFP antibody. In agreement with previous studies (13, 24), CreA
protein levels increased upon the addition of glucose in the WT strain. This increase
was also observed for the strains harboring the CreA point mutations, although protein
concentrations differed significantly compared to those in the WT strain (Fig. 5). The
S262A, S268A, and T308A strains presented significantly reduced CreA protein levels
under CC-derepressing conditions compared to those in the WT strain (Fig. 5a and c).
In the S319A strain, total CreA protein levels were significantly increased under all
FIG 5 CreA phosphomutations affect protein accumulation. Strains were grown in minimal medium (MM)
supplemented with 1% (wt/vol) xylose for 24 h before 2% (wt/vol) glucose was added for 30min. Total cellular
proteins were extracted, and CreA-GFP was immunoprecipitated. Samples were run on a protein gel and
Western blotting was carried out (top). The red arrow indicates full-length CreA-GFP in the presence of xylose
(a) and xylose and glucose (b). The bottom shows the total protein input used for immunoprecipitation as
stained with Coomassie blue. Furthermore, Western blotting of total protein extract for b-actin antibody was
performed and used for normalization. (c and d) Graphs representing densitometry scans of the Western blots
described in panels a and b, respectively. Densitometry values for CreA-GFP were normalized by the input.
Standard deviations represent the averages from three biological replicates (shown as orange symbols). *, P ,
0.05; **, P , 0.01; ***, P , 0.001 in a two-way ANOVA multiple-comparison test using the WT as a reference for
each condition.
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conditions compared to those in the WT strain (Fig. 5), which is in agreement with a
previous study (28). Strains harboring the S262A and S268A mutations also presented
significantly reduced CreA protein levels in the presence of glucose compared to that
in the WT strain (Fig. 5b and d). In contrast, the strain harboring the T308A mutation
presented CreA protein levels that were significantly increased in the presence of glu-
cose compared to that in the WT strain (Fig. 5b and d). Our ChIP-seq analysis showed
that CreA-GFP binds to its own promoter region, suggesting autoregulation (Fig. 2b).
Binding affinities were similar between the WT and S319A strains but significantly
reduced in the S262A, S268A, and T308A strains (Fig. 2b). Additional posttranslational
mechanisms of self-regulation are likely to exist, as CreA-GFP protein accumulation
was similar in strains T308A and S319A, whereas DNA binding was not. Further studies
are required to elucidate the mechanism on how CreA stability is regulated. These
results indicate that the CreA phosphomutations affect CreA protein concentrations.
CreA phosphomutations result in a dysregulated glycogen and trehalose
metabolism. Glycogen metabolism has also been shown to be under the regulatory
control of CreA and its homologues in several fungi, with the lack of CreA causing an
accumulation of intracellular glycogen (14–16). In A. fumigatus, CreA is required for the
expression of gdbA, encoding the glycogen debranching enzyme, and in the absence
of CreA, intracellular glycogen levels increase due to the activity of glycogen synthase
and the absence of GdbA (14). Unexpectedly, our ChIP-seq analysis showed no binding
of A. nidulans CreA-GFP to the gdbA promoter region, indicating possible indirect regu-
lation of glycogen synthesis by CreA. To determine whether glycogen metabolism was
impaired in strains harboring the CreA point mutations, the glycogen levels were used
as a reporter in an assay checking indirect CreA function. We first quantified glucose
transport in these strains, as glucose is the precursor in glycogen biosynthesis. Strains
were grown in complete medium for 24 h before being transferred to MM supple-
mented with 1% glucose for 24 h. Glucose concentrations were measured in culture
supernatants at different time points. The WT strain consumed all extracellular glucose
after 16 h, and glucose transport did not differ significantly between strains for the first
10 h. After 17 h and 19 h, extracellular glucose remained in culture supernatants of
strains harboring the S262A and S268A mutations, suggesting that these strains were
delayed in glucose transport (Fig. 6a). These results suggest that glucose transport is
not impaired in the CreA mutation strains. Next, we measured intracellular glycogen
concentrations when the WT, S262A, S268A, T308A, and S319A strains were grown in
MM supplemented with xylose for 24 h, the condition when glycogen is required as a
carbohydrate storage compound, providing a carbon source to the fungus. We used
the CreAd30 strain, which carries a truncation of CreA (9) to show lack of function of
CreA. In agreement with results in the A. fumigatus DcreA strain, truncation of A. nidu-
lans creA resulted in an accumulation of intracellular glycogen that was almost 10-fold
higher than the glycogen concentrations in the WT strain (Fig. 6b). The S262A and
T308A strains also had significantly increased glycogen levels, although not to the
same concentration as the CreAd30 strain, whereas the S319A strain had significantly
reduced intracellular glycogen levels compared to those in the WT strain (Fig. 6b). The
S268A point mutation did not affect intracellular glycogen concentrations. These
results suggest that A. nidulans CreA is also involved in the regulation of glycogen me-
tabolism and that the CreA phosphomutations affect the function of CreA.
In A. fumigatus, the inability to use glycogen, such as cell wall polysaccharides, as a
precursor carbon source for cellular metabolic pathways results in the fungus using tre-
halose, which is another major intracellular carbohydrate storage compound (14). Our
ChIP-seq results already showed that CreA binds to the promoter region of treA, coding
for an enzyme involved in trehalose metabolism (Fig. 2b). The S262A, S268A, and
T308A strains showed reduced DNA-binding affinity for treA compared to that of the
wild-type strain (Fig. 2b). To determine whether trehalose metabolism is affected by
our CreA point mutations, we measured intracellular trehalose concentrations under
the same conditions as described above. In agreement with reference 9 and studies in
A. fumigatus, the A. nidulans CreAd30 strain had significantly reduced intracellular
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trehalose levels (Fig. 6c). Consistent with our ChIP-seq data, strains harboring the CreA
point mutations S262A, S268A, and T308A also had significantly decreased intracellular
trehalose concentrations compared to that in the WT strain, whereas the strain with
the S319A mutation had significantly increased trehalose levels (Fig. 6c). In summary,
these results suggest that the S262A and T308A point mutations impair CreA function
for the regulation of glycogen and trehalose metabolism. Furthermore, glycogen and
trehalose levels were the opposite in the S319A point mutation strain compared to
those in the CreAd30 strain, suggesting that this mutation may increase the CreA re-
pressive regulatory control of glycogen and trehalose metabolism.
DISCUSSION
The main regulator of CCR in biotechnologically relevant fungi is a C2H2-type TF,
which is termed CreA in the reference fungus A. nidulans. Regulation of CreA itself is
highly complex and involves protein-protein interactions and posttranslational modifi-
cations which ultimately control CreA cellular localization and protein turnover dynam-
ics (13, 24). Although posttranslational modifications have been shown to occur on
FIG 6 CreA phosphomutations affect glycogen and trehalose metabolism. (a) Glucose transport is
not impaired in the CreA-GFP phosphomutants. Strains were grown for 24 h in complete medium
and then transferred to minimal medium (MM) supplemented with glucose for 24 h. Supernatant
samples were collected at the indicated time points, and glucose concentrations were measured
using the glucose oxidase kit God-PAP. (b) CreA controls glycogen metabolism. Strains were
grown in MM supplemented with xylose for 24 h before glycogen was extracted and digested
with amyloglucosidase, and the concentration of free glucose was measured as described for
panel a. The creAd30 strain was used as a control. (c) CreA controls trehalose metabolism. Strains
were grown under the same conditions as described for panel b, before total cellular protein was
extracted and 5mg was used to quantify intracellular trehalose concentrations using the
Megazyme trehalose assay kit. Standard deviations represent the averages from three biological
replicates (shown as orange symbols). *, P , 0.05; **, P , 0.01; ***, P , 0.001 in a two-way
ANOVA multiple-comparison test using the WT as a reference for each condition.
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fungal CreA homologues (23, 44–46), in-depth studies describing these modifications
have not been reported to date. This study attempts to characterize CreA posttranslational
events, including sumoylation, ubiquitylation, and phosphorylation, under the condition
where CCR occurs. Sumoylation and ubiquitylation were not identified on CreA. It is still
possible that these posttranslational events occur on CreA but under other conditions,
such as shorter or prolonged incubation times in glucose or in the presence of other car-
bon sources. Alternatively, these modifications could occur on CreA protein interaction
partners, resulting in the degradation of the whole complex. Previous work has shown
that ubiquitylation is required for CreA degradation processes in the absence of glucose
(13); however, the CreB deubiquitinating enzyme does not directly act on CreA, and it is
involved in CCR regulation (47). The ubiquitylation process is likely to occur on proteins
which form a complex with CreA. Detecting the presence of additional posttranslational
modifications on CreA under different conditions remains a subject for future
investigations.
In contrast, several phosphorylation sites were detected on CreA under conditions
that induce CCR, indicating that this posttranslational modification is important for
CreA regulation in the presence of glucose. The detection of CreA phosphorylation
agrees with studies on S. cerevisiae Mig1p (CreA homologue), Aspergillus oryzae CreA,
and T. reesei CRE1. In S. cerevisiae, the absence of glucose causes the phosphorylation
and activation of the protein kinase Snf1p, which subsequently translocates to the nu-
cleus; in the nucleus, Snf1p phosphorylates Mig1p, causing Mig1p to unbind from tar-
get DNA sequences and to translocate to the cytoplasm, thus alleviating Mig1p-medi-
ated repression of target genes (21). In A. oryzae, phosphorylation in the C-terminal region
affects CreA cellular localization and degradation (23), whereas phosphorylation of T. reesei
CRE1 serine 241 is crucial for CRE1 DNA binding in the presence of glucose (30). Previous
work has shown that Stk22 (a kinase working as an activator of SnfA) is regulated by PkaA
and acts on CreA (28). In A. nidulans, SnfA is not predicted to target CreA for phosphoryla-
tion, and SnfA has never been identified as a CreA interaction partner (24). On the other
hand, CreA requires SnfA for normal localization in the cytoplasm (3). These studies sug-
gest that SnfA regulates CreA indirectly through an as-yet-unknown mechanism.
The phosphorylation sites identified by MS in this work, with the exception of CreA
S277 (predicted to be phosphorylated by PkaA) and S406 (predicted to be phosphoryl-
ated by an unspecific protein kinase), were predicted in silico to be phosphorylated
(Fig. 1a), indicating that the bioinformatics tool NetPhos is a good starting point for
detecting potential phosphorylation sites on Aspergillus proteins. The acidic and con-
served domains show an increased concentration of phosphorylation sites, suggesting
that these regions are important for glucose-mediated CCR. Deletion of these CreA
regions has been shown to affect CreA cellular localization and growth in the presence
of different carbon sources (13). In agreement, mutation of S262, S268, T308, and S319
to alanines also resulted in strains with defects in CreA cellular localization (with the
exception of S319, which shows a delay in CreA transport to the nucleus [28]), DNA-
binding affinity, and protein accumulation, with consequences for the regulation of
enzyme activities and glycogen and trehalose metabolism (Fig. 2 and 6). Interestingly,
the S319A point mutation, which localizes outside the acidic and conserved domains,
resulted in a strain that showed different, often opposing, phenotypes than the strains
harboring the S262A, S268A, and T308A mutations, which are located around the
acidic and conserved domains. For example, binding to the xlnR promoter region was
reduced in the S319A strain, although xylanase activity was not affected as was observed
for the other phosphomutation-harboring strains. It is possible that phosphorylation sites
located within or close to the acidic and conserved domains are important for structural
organization and function of CreA. Phosphosites may also affect protein-protein interac-
tions and subsequent signaling events, resulting in phenotypes that cannot be explained
by DNA-binding capacity alone. This is further supported by our findings where differences
in CreA-GFP-binding affinities to the creA promoter region do not necessarily reflect subse-
quent cellular protein levels. Another intriguing possibility is that different parts of the
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protein have separate functions, which depend on the condition-specific phosphorylation
pattern. Again, CreA posttranslational events need to be further characterized under other
biotechnologically relevant conditions. In addition, future studies that include protein-pro-
tein interactions of CreA phosphomutants will also be highly informative on the regulatory
processes underlying CCR.
Economically feasible conversion of plant biomass to simple sugars by filamentous
fungi requires the attenuation or absence of CCR in order to ensure continuous
enzyme secretion (48). Regulation of CCR necessitates the expression of protein-encod-
ing genes that are essential for fungal survival and growth and can therefore not be
deleted, whereas promoter replacement of these essential genes is often leaky and
inefficient (49). Mutation of phosphorylation sites, as described in this work, is an alter-
native for attenuating CCR and increasing enzyme secretion in the presence of glucose
without affecting fungal growth.
In this study, we show that the absence of CreA phosphorylation sites affect protein
concentrations under both CC-derepressing and CCR conditions. The phenotypes
observed for each point mutation-harboring strain are summarized in Table 1. The
S262A and S268A mutations cause a significant reduction of CreA protein levels under
all conditions (Fig. 5). Accordingly, we observed an increase in xylanase gene expres-
sion (Fig. 3) and enzyme activities (Fig. 4c and d) as well as intracellular glycogen and
trehalose levels that are similar to those in the creAd30 strain (Fig. 6b and c), suggesting
that these mutations inactivate CreA. In contrast, CreA nuclear localization is increased
in the S262A and S268A strains under CC-derepressing conditions. In the S262A strain,
we observed a DNA binding affinity for xylan/xylose genes similar to that in the WT
strain, despite this strain presenting reduced CreA protein levels, thus resulting in
increased xylanase activity (Fig. 2e, 4d, and 5). These results highlight the necessity to
carry out both transcriptional and posttranslational characterizations. Similarly, CreA
nuclear accumulation was increased in the S268A strain, whereas DNA-binding affinity
for xylan/xylose genes was reduced, again resulting in an increase in enzyme activities
(Fig. 4c and d). Both the S262 and S268 phosphosites are predicted to be phosphorylated
by the essential protein kinase CkiA, and indeed, when placing ckiA under the thiamine-re-
pressible promoter, a CC-derepressing phenotype is observed (24).
In the S319A strain, xylanase activity was significantly reduced despite no changes
in CreA nuclear localization and reduced binding affinities for genes encoding enzymes
required for xylan degradation. This discrepancy is possibly due to the high CreA pro-
tein levels observed in the S319A mutant (Fig. 5). Similarly, CreA cellular localization
patterns, DNA-binding affinities, and glycogen and trehalose concentrations as well as
TABLE 1 Phenotype summary
Phenotype
Value or description for phosphosite:
WT S262A S268A T308A S319A
Phosphosite conservationa F (all tested) F (A. nidulans) F and Y (C. neoformans,
C. albicans)
F (A. nidulans, T. reesei,
F. graminearum)
Radial growth, allyl alcohol (40mM) (%) 44.68 8.96 10.02 10.64 54.76
Radial growth, 2DG (0.25mM) (%) 33.67 38.1 32.6 49.57 34.04
Nuclear CreA-GFP (glucose) (%) 93.52 70.2 77.9 16.41 93.88
ADH activity (glucose1ethanol) (mUmg/mg protein) 3.47 5.43 2.43 4.35 4.15
RT-qPCR for xlnA (30-min glucose1xylose) (fold increase) 140.11 443.35 646.46 886.86
246.05
Xylanase activity (72-h glucose1xylose) (mUmg/mg
protein)
11.82 21.43 22.38 35.9 14.56
Stability of CreA protein (30-min glucose) (GFP/
Coomassie ratio)
0.16 0.08 0.07 0.81 0.88
Glucose supernatant (%) (17-h transport) 5.74 17.77 32.56 11.96 5.74
Glycogen (mg/mg of protein) 0.046 0.068 0.048 0.071 0.01
Trehalose (mg/mg of protein) 0.038 0.028 0.013 0.017 0.045
aF, filamentous fungi; Y, yeast.
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enzyme activities are also not in agreement with each other in the T308A strain. This
mutant showed high CreA protein levels in the presence of glucose; however, the T308
mutant has reduced DNA binding and nuclear localization of CreA, events that to-
gether result in a CC-derepressing phenotype. This point mutation is predicted to be
phosphorylated by the protein kinase GskA. GskA-GFP studies showed a predominant
cytoplasmic localization (24), suggesting that CreA phosphorylation by GskA takes
place in the cytoplasm and that this event is required for CreA translocation into the
nucleus (Fig. 4a and b). Pharmaceutical inhibition of GskA by GSK3b-VII strongly sug-
gests involvement of this protein kinase in CCR via regulation of the mitogen-activated
protein kinase kinase (MAPKK) PbsA (50). These results highlight the regulatory com-
plexity at both transcriptional and posttranslational levels that govern CreA, suggest-
ing additional mechanisms which probably occur posttranslationally.
We also attempted to replace the S262, S268, T308, and S319 residues with glu-
tamic acids in order to mimic constant phosphorylation but were unable to do so,
even in a diploid strain carrying a heterozygous mutation resulting in a very sick and
unviable strain, suggesting that these mutations result in a lethal dominant phenotype.
Indeed, in Candida albicans, hyperactivation of Mig1p due to Snf1 deletion resulted in
a lethal dominant phenotype, suggesting that correct levels of this regulator and DNA
binding are important for fungal survival (51).
Under CC-derepressing conditions, CreA is localized in the cytoplasm and the nu-
cleus (1, 3, 13, 24), with cytoplasmic CreA forming a complex with Fbx23, which signals
degradation of these proteins (Fig. 7a). Although CreA posttranslational modifications
remain to be fully characterized under CC-derepressing conditions, it is likely that little
phosphorylation occurs on this protein under these conditions, as suggested previ-
ously (29). Upon the addition of glucose, several phosphorylation events, which are cata-
lyzed by different protein kinases, occur on the CreA acidic and conserved domains, result-
ing in CreA translocation to the nucleus, binding to target gene promoter regions such as
alcA, alcR, treA, and xlnR promoters, and induction of CCR (Fig. 7b). Another protein kinase
involved in this process is PkaA (catalytic subunit of PKA), previously shown to be required
for CreA stability (50). ChIP-seq under CCR found CreA-GFP binding to the xlnR and xlnD
FIG 7 Diagram showing the phosphorylation events that occur in the presence of glucose. (a) CreA forms a cytoplasmic complex with the corepressors
RcoA and SsnF, the protein kinases GskA and CkiA, and the F-box protein Fbx23 in the presence of alternative carbon sources, such as xylan (24). Under
these conditions, CreA is also present in the nucleus with the corepressors, although DNA binding is not occurring. PkaA is also involved indirectly in the
process, regulating CreA stability and localization (1, 28, 50). (b) Glucose is taken up into the cells, where it undergoes glycolysis and phosphorylation, a
step that has been shown as a crucial signal for CreA translocation to the nucleus. Upon glucose signal detection, Fbx23 dissociates from the complex,
CreA phosphorylation increases, and it translocates to the nucleus without the protein kinases. In the nucleus, CreA binds to target genes and causes
repression.
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promoters and additional genes involved in xylan/xylose metabolism (Fig. 2b and c).
Previous work showed that although xlnD is under the control of CreA, its expression is
partially controlled by XlnR (18). Our results showed that CreA binds directly to the xlnR
and xlnD promoters (Fig. 2c), explaining xlnD derepression when CreA function is affected
and xlnA, xlnB, and xlnC derepression (controlled by XlnR) (18, 48, 52).
The here-described phosphomutant-associated phenotypes can serve as starting
points for strain engineering in order to modify CreA without the need to carry out
whole gene deletions in biotechnologically relevant fungi and for studying CreA
homologues in plant and human-pathogenic fungi, where it was shown to be impor-
tant for the infection process (51, 53–55). In summary, our results indicate that CreA is
regulated by posttranslational events that are predicted to be controlled by different
protein kinases. The exact regulatory mechanism exerted by these enzymes remains a
subject for future investigations, but conservation of these phosphorylation sites in a
number of fungi as well as a functional conservation of this TF in these organisms sug-
gests similar regulatory mechanisms.
MATERIALS ANDMETHODS
Strains and culture conditions. Strains used in this study are described in Table S2 available at
10.6084/m9.figshare.13181990. GFP-tagged CreA and CreA point mutations were constructed in the
AGB551 background strain as described previously by de Assis et al. (24). Briefly, point mutations in CreA
were introduced by generating two fragments by PCR, using the CreA-GFP strain as a template, for cas-
sette construction: (i) the 59 UTR (untranslated region) and the CreA open reading frame (ORF) spanning
until 3 bp before the point mutation and (ii) the rest of the CreA ORF, which overlaps 20 bp with the 59
UTR-CreA ORF and contains three different base pairs for amino acid substitutions in the gfp gene, the
marker gene, and the 39 UTR. Fragments were ligated using S. cerevisiae strain SC9741 and plasmid
pRS426 as described previously (13). Cassettes were amplified by PCR from positive candidates by using
the TaKaRa high-fidelity polymerase (Clontech) and subsequently transformed into A. nidulans as
described previously (24). Strains were confirmed by sequencing. Strain CreAd30 was kindly provided by
M. Orejas. All culture medium and growth conditions were as described previously (1, 13).
CreA phosphorylation site prediction and protein alignment. Phosphorylation sites on CreA were
predicted by submitting the CreA protein sequence (retrieved from FungiDB) to NetPhos3.1 (http://
www.cbs.dtu.dk/services/NetPhos/) and using the default filters. Significant predicted phosphorylation
sites were considered those having a score higher than 0.5 (31, 32). Alignment between CreA and its
homologues from other fungi was carried out using SnapGene multiple-sequence alignment software
and analyzed at ESPript 3.0 (http://espript.ibcp.fr/ESPript/cgi-bin/ESPript.cgi). All protein sequences were
obtained from the UniProt database (https://www.uniprot.org).
Growth in the presence of 2-deoxyglucose and allyl alcohol. Strains were grown from 107 conidia
on minimal media (MM) (1) supplemented with 1% (wt/vol) xylose or glucose and increasing concentra-
tions of 2DG or AA, respectively, for 5 days at 37°C or 30°C. Colony diameters were measured from bio-
logical triplicates.
Microscopy. Strains were grown for 16 h at 22°C in 5ml MM supplemented with 1% (wt/vol) xylan
or ethanol in small petri dishes containing a coverslip before glucose was added to a final concentration
of 2% (vol/vol). Samples were then incubated an additional 30min. Coverslips containing the attached
hyphal germlings were viewed under a Carl Zeiss (Jena, Germany) Axio Observer Z1 fluorescence micro-
scope using the 100 oil immersion lens objective (EC Plan-Neofluar, numerical aperture [NA] 1.3).
Differential interference contrast (DIC) and fluorescence images were taken and processed, and the per-
centage nuclear CreA-GFP was calculated as described previously (13).
Alcohol dehydrogenase activity. ADH activity was determined as described previously (56). Briefly,
total cellular proteins were extracted from strains grown under the defined conditions, and 10mg of
total cellular protein was used to measure ADH activity in a total reaction volume of 200ml. Proteins
were first mixed with reaction buffer (50mM sodium pyrophosphate decahydrate, 50mM semicarbazide
hydrochloride, and 20mM glycine, pH 8.0) before the reaction was started with 6mM NAD1 and incu-
bated at 37°C for 15min. Enzyme activity was measured at 340 nm in a 96-well plate using a Synergy
HXT microplate reader (Biotek). The linear part of the slope was used to calculate enzyme activity, which
was expressed as milliunits  milliliters per milligram protein. ADH activity was measured in biological
and technical triplicates.
Xylanase activity. Xylanase (endo-1,4-b-xylanase) activity in culture supernatants of biological tripli-
cates was performed using Azo-Xylan from birch-wood (Megazyme) as a substrate according to the
manufacturer’s instructions. Technical triplicates were carried out for each biological replicate.
Chromatin immunoprecipitation followed by next-generation sequencing and bioinformatics
analysis. The AGB551 (GFP-free, control WT strain) and CreA-GFP phosphomutation-harboring strains
were cross-linked in 1% formaldehyde for 20 min at room temperature with gentle shaking. Experiments
were performed with biological triplicates. Chromatin preparation was performed as described previ-
ously (57). Immunoprecipitation and library preparation for multiplex Illumina sequencing were carried
out as described previously (58, 59). Illumina sequencing was performed on a HiSeq 2500 at the Gene
Expression and Single Cell core facility of Faculty of Health Sciences at University of Macau. Sequencing
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data processing was carried out as described in reference 60. Bowtie2 (61) was used to align reads to
the Aspergillus nidulans reference genome (version s10-m04-r03). CreA binding peaks were identified
using MACS2 (62). ChIP-seq summits within 200 bp from different samples were merged as one by the
mergePeaks program from the Homer software package (63). The reported ChIP-seq summits from
mergePeaks were mapped to the closest gene to identify CreA target genes. CreA binding levels at tar-
get genes were calculated by counting normalized ChIP-seq read counts within a 200 bp window span-
ning the peak summit at corresponding promoters. For promoters with multiple CreA binding sites, the
binding signal at each peak summit was calculated, and the sum for all peaks on the same promoter
was reported. The violin plot was generated using FungiExpresZ (https://cparsania.shinyapps.io/
FungiExpresZ/).
Glucose transport. Strains were grown from 107 conidia in 30ml complete medium for 24 h,
washed twice with double-distilled water (ddH2O), and transferred to MM supplemented with 1% (wt/
vol) glucose for 24 h. Two hundred microliters was collected from the culture supernatants at the desig-
nated time points, and residual glucose (percent residual glucose in the supernatant compared to that
at time zero) was measured using the Glucose GOD-PAP Liquid Stable Mono-reagent kit (LaborLab
Laboratories Ltd., Guarulhos, São Paulo, Brazil) according to manufacturer’s instructions.
Intracellular glycogen and trehalose concentrations. Intracellular glycogen and trehalose levels
were measured in mycelia grown 24 h in MM supplemented with xylose as a carbon source as described
previously (14).
RNA extractions, cDNA biosynthesis, and qRT-PCRs. RNA extractions of mycelia grown in biologi-
cal triplicates were performed using TRIzol (Life Technologies), according to the manufacturer’s instruc-
tions. cDNA was synthesized from 1mg RNA using the ImProm-II reverse transcriptase (Promega) kit,
according to the manufacturer’s instructions. For each qRT-PCR, 1ml cDNA was used, and the PCR set up
was exactly as described previously (13). Gene expression was normalized by tubC (tubulin), whose
expression remains constant under all tested conditions.
Protein extraction and Western blotting. Crude protein extracts from mycelia were obtained by
extraction from ground mycelia with B250 buffer (250mM NaCl, 100mM Tris-HCl [pH 7.5], 10% glycerol,
1mM EDTA, and 0.1% NP-40) supplemented with 1.5ml/liter 1 M dithiothreitol (DTT), 1 pill/10ml
cOmplete Mini protease inhibitor cocktail, EDTA free (Roche), 3ml/liter 0.5 M benzamidine, 1 pill/10ml
phosSTOP phosphatase inhibitors, and 10ml/liter 100mM phenylmethylsulfonyl fluoride (PMSF).
Western blotting was carried out as described previously (24). Protein extracts from biological triplicates
were used to carry out the Western blot experiments.
Immunoprecipitation (GFP pulldown). Total protein lysates from the WT (GFP-negative, negative
control), the CreA-GFP (positive control), and the CreA-GFP phosphomutation-harboring strains grown
in biological triplicates were centrifuged at 10,400 g at 4°C for 10min before the supernatant was col-
lected into a new microcentrifuge tube. GFP-trap beads (Chromotek) were equilibrated with B250 lysis
buffer (20 ml of beads into 500 ml lysis buffer B250) for 10min before they were collected by centrifuga-
tion according to the manufacturer’s instructions and incubated with 6mg of total protein lysate at 4°C
for 3 h. After incubation with protein lysates, GFP-trap beads were collected, and the supernatant was
removed. The GFP-trap beads were washed two times with 1ml B250 lysis buffer without DTT, and one
additional wash step was carried with the addition of DTT. GFP-trap beads were collected, and the su-
pernatant was removed.
Proteolytic digestion of protein after GFP pulldown. Dried GFP-trap eluates were solubilized in
50ml of 50mM triethylammonium bicarbonate (TEAB) in 50:50 (vol/vol) trifluoroethanol (TFE) to water.
Protein thiols were reduced and carbamidomethylated in one step (thermomixer at 70°C, 500 rpm,
30min) by addition of 500 nmol tris(2-carboxyethyl)phosphine (TCEP) and 625 nmol 2-chloroacetamide
(each solubilized in 100mM aqueous TEAB). Subsequently, the protein solution was concentrated to a
final volume of approximately 5ml using a vacuum concentrator and diluted with 45ml 100mM TEAB to
gain a final volume of 50ml. Tryptic cleavages were performed using 1mg rLys C (Promega number [no.]
V1671) with incubation for 2 h at 37°C, and subsequently, 2mg Trypsin Gold (Promega no. V5280) was
added and the mixture was incubated for a further 16 h at 37°C. GluC cleavages were performed using
2mg GluC (Promega no. V1651) and incubating for 18°C at 37°C. Peptides were dried and resolubilized
in 25ml 0.05% trifluoroacetic acid and 2% acetonitrile using a water bath sonicator (15min). Finally, the
samples were filtered through 0.2-mm spin filters (Merck Millipore Ultrafree-MC, hydrophilic polytetra-
fluoroethylene [PTFE] membrane, catalog no. UFC30LG25) at 18,000 g for 15min, and the filtrate was
transferred into high-performance liquid chromatography (HPLC) vials.
Phosphoproteome analysis by LC-MS/MS. Proteome analysis, including phosphosite identification,
was performed by nanoflow liquid chromatography coupled to tandem mass spectrometry (nLC-MS/
MS) as recently published (64).
Protein database search and data analysis. Tandem mass spectra were searched against the
FungiDB protein database of Aspergillus nidulans FGSC A4 (https://fungidb.org/common/downloads/release
-44/AnidulansFGSCA4/fasta/data/FungiDB44_AnidulansFGSCA4_AnnotatedProteins.fasta), the pro-
tein sequence of CreA-GFP using Proteome Discoverer (PD) 2.2 (Thermo), and the algorithms of Mascot
2.4.1, Sequest HT (version of PD2.2), and MS Amanda 2.0. Two missed cleavages were allowed for both tryp-
tic and GluC digestion. The precursor mass tolerance was set to 10ppm, and the fragment mass tolerance
was set to 0.02Da. Modifications were defined as dynamic oxidation of Met, acetylation of the protein N ter-
minus, phosphorylation of Ser, Thr, and Tyr, and either ubiquitination (GG, tryptic cleavage) or SUMOylation
of Lys (QIGG/QIGGG, GluC cleavage) as well as static Cys carbamidomethylation. A strict false-discovery rate
(FDR) of ,1% was required for positive protein hits. The Percolator node of PD2.2 and a reverse decoy
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database was used for q value validation of spectral matches. Only rank 1 proteins and peptides of the top
scored proteins were counted. The Minora algorithm of PD2.2 was applied for relative label-free
quantification.
Statistical analysis. Statistical analysis was performed on a minimum of three biological replicates
using a two-way analysis of variance (ANOVA) multiple-comparison test or a one-tailed t test (Prism
GraphPad). Comparisons were carried out with reference to the wild-type strain under all conditions.
Data availability. The mass spectrometry proteomics data have been deposited to the
ProteomeXchange Consortium via the PRIDE (65) partner repository with the data set identifier
PXD018967. ChIP-seq results were submitted to NCBI under accession number SUB7547091.
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